Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TriReme Medical LLC

Division of QT Vascular Ltd.

Latest From TriReme Medical LLC

New Product Briefs

DexCom’s “professional” continuous glucose monitor, Cook launches Zilver PTX drug-eluting peripheral stent and more product news.

Medical Device

Medical Device Deals Update, April 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced March-April 2014.

Medical Device

Deals Shaping The Medical Industry, April 2014

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced February through March 2014.

BioPharmaceutical Medical Device

Vascular Interventional Devices: New Avenues For Growth

Manufacturers are finding it harder to innovate in the vascular interventional devices as market and regulatory pressures take their toll. New coronary drug-eluting stents face a difficult challenge with the high bar now set by existing devices, and there have been several recent disappointments in renal denervation, drug-coated balloons, and renal artery stenting; still there are some promising areas, with bioresorbable stents offering perhaps the best prospect among vascular therapies for future blockbuster status.

Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Cardiovascular
  • Alias(es)
  • TriReme Medical Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • QT Vascular Ltd.
  • Senior Management
  • Eitan Konstantino, PhD, Pres. & CEO
    Randal H Farwell, CFO
    Christopher Haig, VP, Mktg., Sales & Bus. Dev.
    Maria Pizarro, VP, R&D
    John Burrell, VP, Sales
  • Contact Info
  • TriReme Medical LLC
    Phone: (925) 931-1300
    7060 Koll Canter Pkwy.
    Suite 300
    Pleasanton, CA 94566
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register